Valeant and Pershing Square Reach an Agreement on Cost-Sharing Related to Allergan Litigation

By Staff
Friday, February 17, 2017 12:23 AM LAVAL, Quebec—Valeant Pharmaceuticals International has entered into an agreement with William Ackman and his Pershing Square Capital Management group that covers the distribution of legal and settlement costs related to a long-running battle with Allergan shareholders, according to a Securities and Exchange Commission filing earlier this week.

Vision West Ongoing Financial Support to the California Optometric Association Tops $12.4 million

By Staff
Friday, February 17, 2017 12:18 AM SAN DIEGO, Calif.—Vision West presented a check to the California Optometric Association for $203,939 at the recent COA House of Delegates meeting held in San Francisco on Feb. 10.

In Response to Court Rulings, Aetna-Humana and Cigna-Anthem Call an End to Merger Plans

By Staff
Wednesday, February 15, 2017 12:21 AM NEW YORK—Valentine’s Day was not so sweet for the four leading U.S. health plans. The sweeping consolidation of U.S. health plans will not come to fruition, at least in the combos of Aetna/Humana and Cigna/Anthem.

Strong Performance of Restasis in Fourth Quarter Helps Allergan to Strong 2016 Finish

By Staff
Friday, February 10, 2017 12:23 AM DUBLIN— Allergan plc (NYSE: AGN) this week reported financial results showing adjusted revenue of $3.9 billion in the fourth quarter, an increase of 7 percent, which the company attributed to “strong performance” from its facial aesthetics, eyecare and new product launches, among other factors.

Luxottica Group Reports Preliminary 2016 FY Sales, Also Acquires Brazil’s Opticas Carol Group

By Staff
Wednesday, February 1, 2017 12:29 AM MILAN—Luxottica Group S.p.A. (MTA: LUX; NYSE: LUX) reported consolidated net sales and preliminary results for the fourth quarter and the full fiscal year 2016 here.

Hoya’s Revenue Drops But Profit Increases in 3Q 2016

By Staff
Wednesday, February 1, 2017 12:26 AM TOKYO—Hoya Corp. (TOKYO:7741) reported a decrease in revenue but an increase in profit for the third quarter ended Dec. 31, 2016.

Safilo Group S.p.A. Reports Preliminary Q4 and FY 2016 Sales

By Staff
Wednesday, February 1, 2017 12:23 AM PADOVA, Italy—Safilo Group S.p.A. (Reuters SFLG.MI) reported that preliminary figures for fiscal year 2016 showed full year total net sales reached €1,252.8 million, contracting slightly compared to the €1,279.0 million recorded in full year 2015 (down 2.0 percent at current exchange rates and a dip of 1.2 percent at constant exchange rates) as a result of the negative impact of the brands that the Group stopped servicing. In the year, sales of Safilo’s Going Forward Brands Portfolio increased 3.6 percent at constant exchange rates or a gain of 5.2 percent, excluding Retail.

GrandVision Reports Higher Preliminary Q4 and Fiscal Year Revenues and Comps

By Staff
Monday, January 30, 2017 12:23 AM
SCHIPOL, the Netherlands—GrandVision NV (EURONEXT: GVNV), reported preliminary and unaudited revenue growth at constant exchange rates of 6.6 percent for its fiscal year 2016 and 8.0 percent for the fourth quarter of the year. Comparable growth in the fourth quarter was 3.8 percent while for the full year, the company said comparable growth was 2.2 percent.

Novartis Reports ‘Solid 2016 Performance’ in Year-End Financial Announcement

By Staff
Friday, January 27, 2017 12:23 AM BASEL, Switzerland—With investment in product launches and the loss of patent exclusivity on a key drug weighing on its financial results, Novartis this week said it managed to deliver “a solid performance” in 2016 with annual sales in line with 2015’s results.

Novartis Considering Options for Alcon Division, Including Spinoff or IPO

By Staff
Wednesday, January 25, 2017 7:30 AM BASEL, Switzerland—Novartis reported Wednesday morning that it is considering various options for its Alcon eyecare division, which it noted “improved basic operations” in 2016’s fourth quarter.

Johnson & Johnson Reports Gains in Full-Year and Fourth-Quarter Sales, Earnings

By Staff
Wednesday, January 25, 2017 12:23 AM NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) reported Tuesday that its worldwide sales totaled $71.9 billion in fiscal 2016, an increase of 2.6 percent compared to 2015, and its adjusted earnings per share (EPS) totaled $6.73, an increase of 8.5 percent.

ForSight VISION4, Inc. Announces Acquisition by Roche

By Staff
Monday, January 16, 2017 12:24 AM MENLO PARK, Calif.—ForSight VISION4 announced that it has been acquired by Roche Holdings Inc.

Second Sight Medical Products, Inc. Announces Rights Offering

By Staff
Wednesday, January 11, 2017 12:23 AM SYLMAR, Calif.—Second Sight Medical Products, Inc. (Nasdaq:EYES) a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a rights offering to its existing stockholders.

3M Completes Sale of Rx Safety Business to Hoya Vision Care

By Staff
Friday, January 6, 2017 12:23 AM ST. PAUL, Minn.—3M (NYSE:MMM) announced on Jan. 3 that it has completed the sale of its safety prescription eyewear business to Hoya Vision Care, a division of Hoya Corp (TOKYO: 7741), a global leader in the eyeglass lens industry.

Zeiss Group Reports Record Revenue and Earnings for 2015-16 Fiscal Year

By Staff
Monday, December 19, 2016 12:23 AM STUTTGART, Germany—The Zeiss Group reported record revenue and earnings for its 2015-16 fiscal year on Friday, and cited “improved competitiveness” for its operational success.
Loading...